RT Journal Article
SR Electronic
T1 Automated Approach to Selecting Neurological Medical Imaging Orders Using Natural Language Processing
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.06.24.23291863
DO 10.1101/2023.06.24.23291863
A1 Mehta, Videet
A1 Dharia, Rohan
A1 Desai, Nilesh
YR 2023
UL http://medrxiv.org/content/early/2023/07/03/2023.06.24.23291863.abstract
AB Medical imaging, like computed tomography (CT) and magnetic resonance imaging (MRI), holds profound value in disease diagnosis for millions worldwide. However, studies show that physician imaging orders may frequently be inappropriate (26% of cases) for the corresponding patient evaluation. Measures are necessary to mitigate patient risks in the subsequent re-imaging necessitated by physician error, including radiation exposure, additional sedation (pediatrics), and delayed treatment. To address these dangers, AIM-AI presents an unprecedented platform for automated medical imaging order selection using natural language processing and machine learning (ML). The algorithm was trained with anonymized imaging records and associated provider-input symptoms for 40,667 patients from Texas Children’s Hospital, obtained after institutional review board approval. First, the data was preprocessed using tokenization and lemmatization to extract keywords. Second, an entity-embedding ML model converted the symptoms to high-dimensional numerical vectors suitable for model comprehension, which we used to balance the dataset through k-nearest-neighbor-based synthetic sampling. Third, a Support Vector Classifier (ML model) was trained and hyper-parameter tuned using the em-bedded symptoms to predict modality (CT/MRI), contrast (with/without), and anatomical region (head, neck, etc.) for an imaging order with 93.2% accuracy on 4,704 test cases. Finally, a web application was developed to package the model, which analyzes user-input symptoms and outputs the predicted order. The implementation of this application would save the lives of millions of patients facing potentially fatal risks associated with medical imaging by reducing costs, expediting treatment, and maximizing patient health. In this way, AIM-AI paves the path to a revolutionized medical field.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of Baylor College of Medicine and Affiliated Hospitals gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data provided in the manuscript is a private dataset from Texas Childrens Hospital not available for request.